In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Is exercise training HR above anaerobic threshold level harmful in patients after acute myocardial infarction with high BNP levels?

Session Poster session 3

Speaker Ayumi Date

Event : ESC Congress 2017

  • Topic : preventive cardiology
  • Sub-topic : Rehabilitation: Outcomes
  • Session type : Poster Session

Authors : A Date (Osaka,JP), T Tokeshi (Osaka,JP), H Miura (Osaka,JP), R Kumasaka (Osaka,JP), K Nakao (Osaka,JP), T Arakawa (Osaka,JP), S Fukui (Osaka,JP), T Hasegawa (Osaka,JP), M Nakanishi (Osaka,JP), M Yanase (Osaka,JP), T Noguchi (Osaka,JP), S Yasuda (Osaka,JP), Y Goto (Osaka,JP)

Authors:
A. Date1 , T. Tokeshi1 , H. Miura1 , R. Kumasaka1 , K. Nakao1 , T. Arakawa1 , S. Fukui1 , T. Hasegawa1 , M. Nakanishi1 , M. Yanase1 , T. Noguchi1 , S. Yasuda1 , Y. Goto1 , 1National Cerebral and Cardiovascular Center Hospital, Cardiovascular Medicine - Osaka - Japan ,

Citation:
European Heart Journal ( 2017 ) 38 ( Supplement ), 517

Background: Exercise training heart rate (TrHR) is recommended to be set at the anaerobic threshold (AT) level for high-risk acute myocardial infarction (AMI) patients such as those having heart failure or left ventricular systolic dysfunction. In addition, high intensity exercise training has been reported to aggravate left ventricular (LV) remodeling in the rat model with extensive AMI. However, it remains unknown whether TrHR slightly above AT is actually harmful in AMI patients with elevated B-type natriuretic peptide (BNP) levels.

Objective: Accordingly, the objective of this study was to clarify the effects of exercise training at TrHR slightly (0–15%) above AT on exercise capacity and BNP levels in high-risk AMI patients with elevated BNP levels at baseline.

Methods: We studied 223 consecutive AMI patients with baseline BNP ≥200pg/ml who participated in our cardiac rehabilitation (CR) program. All patients underwent blood sampling and symptom-limited cardiopulmonary exercise testing (measurements for peak oxygen uptake [PVO2]) at the beginning and the end of the CR. To assess the effects of TrHR below and above AT on PVO2 and BNP, we retrospectively selected consecutive 58 male patients who actively participated in the 3-month supervised outpatient CR program at least once a week and also performed home exercise at least twice a week, according to an individually prescribed TrHR in the range of 90–115% of AT level determined at the initial CPX. They were divided into two groups according to TrHR: Below-AT group (TrHR 97.7±2.6% of AT level, n=13) and Above-AT group (107.0±4.0% of AT level, n=45).

Results: At baseline, age (Below-AT: 71y vs Above-AT: 68y, NS), left ventricular ejection fraction (LVEF; 38 vs 38%, NS), BNP (372 vs 415pg/ml, NS), PVO2 (17.9 vs 18.9 ml/kg/min, NS), number of CR attendance in 3 months (26 vs 29 sessions, NS), and exercise training duration (4.4 vs 5.0 hour/week, NS) and frequency (5 vs 6 times/week, NS) were similar in both groups. Notably, after 3-month CR, Above-AT group showed a significantly greater increase in PVO2 than Below-AT group (5.0% vs 13.9%, P=0.03), with equivalent significant BNP decreases (-221pg/ml vs -212pg/ml, NS). No exercise-related cardiac event occurred in both groups.

Conclusion: TrHR slightly (0–15%, average 7%) above AT level may result in a greater improvements in PVO2 than that slightly below AT level without aggravating BNP even in high-risk AMI patients with elevated BNP levels at baseline.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are